AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Cibus, Inc.

$1.49 -$0.39 (-20.74%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$1.57
Day Range
$1.48$1.62
Year Range
$1.09$4.19
Market Cap
113.73M
AVG Volume
269.73K
Trailing/Forward PE
-0.9/-
PEG ratio
0.04
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
02M4M6M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CBUS Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q24.35M
26 Q14.29M
25 Q43.64M
25 Q33.79M
25 Q24.85M
25 Q14.75M
24 Q44.26M
24 Q34.15M
24 Q22.96M
24 Q12.32M
Net Income (USD) · TTM
-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CBUS Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-98.19M
26 Q1-101.42M
25 Q4-127.08M
25 Q3-118.9M
25 Q2-275.33M
25 Q1-274.84M
24 Q4-251.39M
24 Q3-445.4M
24 Q2-291.86M
24 Q1-285.67M
Operating Income (USD) · TTM
-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CBUS Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-53.94M
26 Q1-58.96M
25 Q4-88.41M
25 Q3-92.98M
25 Q2-277.98M
25 Q1-281.51M
24 Q4-258.4M
24 Q3-260.26M
24 Q2-85.62M
24 Q1-83.45M
EBITDA (USD) · TTM
-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CBUS EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2-58.95M
26 Q1-65.31M
25 Q4-95.4M
25 Q3-90.07M
25 Q2-265.7M
25 Q1-265.84M
24 Q4-241.69M
24 Q3-493.2M
24 Q2-335.13M
24 Q1-336.91M
Cash Flows (USD) · TTM
-80M-60M-40M-20M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CBUS Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-46.32M
26 Q1-50.65M
25 Q4-51.17M
25 Q3-51.71M
25 Q2-53.74M
25 Q1-57.26M
24 Q4-58.85M
24 Q3-62.27M
24 Q2-66.78M
24 Q1-61.86M
EPS (USD) · TTM
-30-20-10024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CBUS EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-1.65
26 Q1-1.97
25 Q4-2.98
25 Q3-3.26
25 Q2-10.45
25 Q1-10.98
24 Q4-10.76
24 Q3-21.91
24 Q2-14.37
24 Q1-13.26
Expenses (USD) · TTM
025M50M75M100MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CBUS Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q257.39M
26 Q163.65M
25 Q471.68M
25 Q376.37M
25 Q281.24M
25 Q183.02M
24 Q478.53M
24 Q378.87M
24 Q285.74M
24 Q184.33M
Shares Outstanding (USD) · TTM
-20M-15M-10M-5M0Buybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CBUS Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-6.77M
26 Q1-7.26M
25 Q4-8.19M
25 Q3-9.08M
25 Q2-9.88M
25 Q1-10.72M
24 Q4-10.75M
24 Q3-12.45M
24 Q2-15.59M
24 Q1-17.79M
Employee Count
050100150200202320242025
CBUS Employee Count by quarter
PeriodEmployee Count
2025118
2024157
2023183
Free Cash Flow Yield
-150%-100%-50%0%med -51.32%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CBUS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-40.5%
Sep 26-38.44%
Sep 26-37.95%
Aug 26-36.57%
Aug 26-35.5%
Aug 26-34.1%
Aug 26-42.92%
Jul 26-40.25%
Jul 26-45.7%
Jul 26-43.4%
Jul 26-38.46%
Jul 26-55.89%
Jun 26-57.12%
Jun 26-57.12%
Jun 26-63.16%
Jun 26-60.22%
May 26-53.95%
May 26-56.29%
May 26-59.3%
May 26-66.85%
May 26-66.39%
Apr 26-64.18%
Apr 26-60.54%
Apr 26-63.75%
Apr 26-48.62%
Mar 26-51.2%
Mar 26-38.82%
Mar 26-25.78%
Mar 26-30.92%
Feb 26-26.48%
Feb 26-32.68%
Feb 26-42.48%
Feb 26-46.98%
Jan 26-50.11%
Jan 26-59.95%
Jan 26-51.43%
Jan 26-51.97%
Jan 26-51.97%
Dec 25-57.48%
Dec 25-57.14%
Dec 25-60.69%
Dec 25-59.58%
Nov 25-71.85%
Nov 25-77.55%
Nov 25-80.09%
Nov 25-98.57%
Oct 25-80.7%
Oct 25-83.31%
Oct 25-83.31%
Oct 25-92.23%
Oct 25-89.67%
Sep 25-99.33%
Sep 25-90.93%
Sep 25-94.95%
Sep 25-100.88%
Aug 25-96.36%
Aug 25-94.25%
Aug 25-91.58%
Aug 25-113.44%
Aug 25-109.64%
Jul 25-101.46%
Jul 25-97.24%
Jul 25-104.72%
Jul 25-105.39%
Jun 25-115.86%
Jun 25-108.9%
Jun 25-109.64%
Jun 25-98.41%
May 25-50.57%
May 25-64.57%
May 25-57.93%
May 25-75.98%
May 25-9.85%
Apr 25-11.49%
Apr 25-13.27%
Apr 25-12.25%
Apr 25-14.58%
Mar 25-11.2%
Mar 25-10.81%
Mar 25-12%
Mar 25-11.95%
Feb 25-12.88%
Feb 25-12.69%
Feb 25-10.43%
Feb 25-10.52%
Jan 25-10.6%
Jan 25-10.91%
Jan 25-10.64%
Jan 25-11%
Jan 25-8.52%
Dec 24-11.19%
Dec 24-9.96%
Dec 24-6.47%
Dec 24-6.29%
Nov 24-5.43%
Nov 24-6.38%
Nov 24-5.83%
Nov 24-5%
Nov 24-6.95%
Oct 24-7.78%
Price to Sales
0100200300400med 26.23Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CBUS Price to Sales by quarter
PeriodPrice to Sales
Sep 2626.31
Sep 2627.72
Sep 2628.07
Aug 2629.13
Aug 2630.02
Aug 2631.25
Aug 2627.54
Jul 2629.36
Jul 2625.86
Jul 2627.23
Jul 2630.73
Jul 2621.15
Jun 2620.69
Jun 2620.69
Jun 2618.71
Jun 2619.62
May 2621.91
May 2620.99
May 2619.93
May 2621.03
May 2621.18
Apr 2621.91
Apr 2623.22
Apr 2622.06
Apr 2628.92
Mar 2627.46
Mar 2636.23
Mar 2652.87
Mar 2644.08
Feb 2651.47
Feb 2641.71
Feb 2632.08
Feb 2629.02
Jan 2627.2
Jan 2622.74
Jan 2626.5
Jan 2626.23
Jan 2626.23
Dec 2523.71
Dec 2523.85
Dec 2522.46
Dec 2522.88
Nov 2518.97
Nov 2517.58
Nov 2517.02
Nov 2511.25
Oct 2513.74
Oct 2513.31
Oct 2513.31
Oct 2512.02
Oct 2512.37
Sep 2511.16
Sep 2512.2
Sep 2511.68
Sep 2510.99
Aug 2511.51
Aug 2511.77
Aug 2512.11
Aug 2510.62
Aug 2510.99
Jul 2511.88
Jul 2512.39
Jul 2511.51
Jul 2511.44
Jun 2510.4
Jun 2511.07
Jun 2510.99
Jun 2512.25
May 2523.83
May 2518.67
May 2520.81
May 2515.86
May 25140.15
Apr 25120.21
Apr 25104.02
Apr 25112.74
Apr 2594.68
Mar 25123.33
Mar 25127.69
Mar 25124.95
Mar 25125.52
Feb 25116.43
Feb 25118.13
Feb 25143.69
Feb 25142.55
Jan 25141.42
Jan 25137.44
Jan 25140.85
Jan 25136.31
Jan 25176.06
Dec 24134.03
Dec 24150.51
Dec 24231.72
Dec 24238.54
Nov 24276.02
Nov 24235.13
Nov 24257.28
Nov 24299.87
Nov 24324.72
Oct 24290.03
Price to Book
02.557.51012.5med 2.92Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CBUS Price to Book by quarter
PeriodPrice to Book
Sep 267.73
Sep 268.14
Sep 268.24
Aug 268.56
Aug 268.82
Aug 269.18
Aug 263.33
Jul 263.55
Jul 263.12
Jul 263.29
Jul 263.71
Jul 262.55
Jun 262.5
Jun 262.5
Jun 262.26
Jun 262.37
May 262.65
May 262.54
May 262.41
May 263.51
May 263.53
Apr 263.65
Apr 263.87
Apr 263.68
Apr 264.82
Mar 264.58
Mar 266.04
Mar 263.86
Mar 263.21
Feb 263.75
Feb 263.04
Feb 262.34
Feb 262.12
Jan 261.98
Jan 261.66
Jan 261.93
Jan 261.91
Jan 261.91
Dec 251.73
Dec 251.74
Dec 251.64
Dec 251.67
Nov 251.38
Nov 251.28
Nov 251.24
Nov 250.73
Oct 250.89
Oct 250.87
Oct 250.87
Oct 250.78
Oct 250.8
Sep 250.73
Sep 250.79
Sep 250.76
Sep 250.72
Aug 250.75
Aug 250.77
Aug 250.79
Aug 250.68
Aug 250.71
Jul 250.76
Jul 250.8
Jul 250.74
Jul 250.73
Jun 250.67
Jun 250.71
Jun 250.71
Jun 250.79
May 251.53
May 251.2
May 251.34
May 251.02
May 256.11
Apr 255.24
Apr 254.53
Apr 254.91
Apr 254.12
Mar 255.37
Mar 255.56
Mar 254.29
Mar 254.31
Feb 254
Feb 254.06
Feb 254.94
Feb 254.9
Jan 254.86
Jan 254.72
Jan 254.84
Jan 254.68
Jan 256.05
Dec 244.6
Dec 245.17
Dec 247.96
Dec 248.2
Nov 249.48
Nov 248.08
Nov 248.84
Nov 2410.3
Nov 243.13
Oct 242.8
Cibus, Inc.
CBUS
Stockpicker

Video analysis: CBUS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CBUS

Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript

seekingalpha.com · 13 Aug 2026

Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript

Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript

Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates

zacks.com · 13 Aug 2026

Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates

Cibus (CBUS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.61 per share a year ago.

Cibus Q2 Earnings Call Highlights

marketbeat.com · 13 Aug 2026

Cibus Q2 Earnings Call Highlights

Cibus NASDAQ: CBUS reported second-quarter 2026 revenue of $1.0 million, compared with $0.9 million a year earlier, as the agricultural biotechnology company advanced its Sustainable Ingredients program and updated the expected timing of its initial rice launch in Latin America.

Cibus Reports Second Quarter Financial Results and Provides Business Update

globenewswire.com · 13 Aug 2026

Cibus Reports Second Quarter Financial Results and Provides Business Update

Commercialization execution advances in Rice and Sustainable Ingredients United States and European Union now aligned on generally treating crops with no added foreign DNA as conventionally bred Quarterly net cash usage declined 19% sequentially and 31% year over year SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a technology company that uses biology to produce sustainable ingredients and helps farmers grow more food with fewer inputs, today announced its financial results for the quarter ended June 30, 2026, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m.

Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call

globenewswire.com · 30 Jul 2026

Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call

SAN DIEGO, July 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a technology company that helps farmers grow more food with fewer inputs, today announced that the company will report second quarter 2026 financial results on Thursday, August 13, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.

Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus

globenewswire.com · 17 Jun 2026

Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus

Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally bred crops, validating the approach Cibus has developed for 25 years Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally bred crops, validating the approach Cibus has developed for 25 years

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.